Eric Molho

7.1k total citations · 1 hit paper
73 papers, 3.7k citations indexed

About

Eric Molho is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Eric Molho has authored 73 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Neurology, 21 papers in Cellular and Molecular Neuroscience and 10 papers in Psychiatry and Mental health. Recurrent topics in Eric Molho's work include Neurological disorders and treatments (44 papers), Parkinson's Disease Mechanisms and Treatments (40 papers) and Botulinum Toxin and Related Neurological Disorders (26 papers). Eric Molho is often cited by papers focused on Neurological disorders and treatments (44 papers), Parkinson's Disease Mechanisms and Treatments (40 papers) and Botulinum Toxin and Related Neurological Disorders (26 papers). Eric Molho collaborates with scholars based in United States, Canada and Australia. Eric Molho's co-authors include Stewart A. Factor, Gerald D. Podskalny, Haydeh Payami, Cyrus P. Zabetian, Diane Brown, Zachary D. Wallen, Erin M. Hill‐Burns, Robert A. Hauser, Paul J. Feustel and James T. Morton and has published in prestigious journals such as Neurology, Journal of Neurophysiology and Neuroscience.

In The Last Decade

Eric Molho

71 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

2017 653 citations Zachary D. Wallen, Stewart A. Factor et al. Movement Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Molho United States	33	2.5k	721	686	644	407	73	3.7k
Karin Wirdefeldt Sweden	27	1.8k 0.7×	579 0.8×	552 0.8×	277 0.4×	449 1.1×	66	2.9k
Shen‐Yang Lim Malaysia	30	3.0k 1.2×	862 1.2×	843 1.2×	406 0.6×	542 1.3×	114	4.2k
Teus van Laar Netherlands	39	4.2k 1.7×	329 0.5×	1.2k 1.8×	716 1.1×	422 1.0×	183	5.6k
L. Côté United States	32	2.4k 1.0×	446 0.6×	816 1.2×	489 0.8×	641 1.6×	51	3.5k
Michela Barichella Italy	32	1.7k 0.7×	700 1.0×	269 0.4×	401 0.6×	684 1.7×	57	2.8k
Ronald F. Pfeiffer United States	45	4.8k 1.9×	1.0k 1.4×	1.4k 2.1×	1.0k 1.6×	1.0k 2.5×	140	7.4k
Roberto Cilia Italy	40	3.1k 1.3×	571 0.8×	1.0k 1.5×	339 0.5×	542 1.3×	104	4.2k
Marie-Françoise Chesselet United States	13	1.8k 0.7×	2.3k 3.2×	1.4k 2.0×	169 0.3×	974 2.4×	13	4.5k
Madelyn C. Houser United States	15	1.0k 0.4×	885 1.2×	335 0.5×	137 0.2×	555 1.4×	36	2.4k
Rob M.A. de Bie Netherlands	39	5.7k 2.3×	516 0.7×	2.4k 3.5×	615 1.0×	401 1.0×	146	6.9k

Countries citing papers authored by Eric Molho

Since Specialization

Citations

This map shows the geographic impact of Eric Molho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Molho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Molho more than expected).

Fields of papers citing papers by Eric Molho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Molho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Molho. The network helps show where Eric Molho may publish in the future.

Co-authorship network of co-authors of Eric Molho

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Molho. A scholar is included among the top collaborators of Eric Molho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Molho. Eric Molho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feustel, Paul J., et al.. (2023). Assessing the Location, Relative Expression and Subclass of Dopamine Receptors in the Cerebellum of Hemi-Parkinsonian Rats. Neuroscience. 521. 1–19. 1 indexed citations

Adam, Octavian, et al.. (2021). Narcolepsy genetic marker HLA DQB1*06:02 and excessive daytime sleepiness in Parkinson disease patients treated with dopaminergic agents. Journal of Neurology. 269(5). 2430–2439. 4 indexed citations

Wallen, Zachary D., William J. Stone, Stewart A. Factor, et al.. (2021). Exploring human-genome gut-microbiome interaction in Parkinson’s disease. npj Parkinson s Disease. 7(1). 74–74. 29 indexed citations

Molho, Eric, et al.. (2020). Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson’s disease. Neuroscience Letters. 739. 135443–135443. 7 indexed citations

Ralbovsky, Nicole M., Lenka Halámková, Dzintra Celmins, et al.. (2019). Multivariate Statistical Analysis of Surface Enhanced Raman Spectra of Human Serum for Alzheimer’s Disease Diagnosis. Applied Sciences. 9(16). 3256–3256. 43 indexed citations

Prusik, Julia, et al.. (2018). Pilot Assessment of Salivary Cortisol Levels as a Marker for Depression in Patients with Parkinson Disease (P3.060). Neurology. 90(15_supplement). 2 indexed citations

O’Connor, Katherine A., et al.. (2017). Effect of diazepam and yohimbine on neuronal activity in sham and hemiparkinsonian rats. Neuroscience. 351. 71–83. 5 indexed citations

Ramirez–Zamora, Adolfo, Lucy Gee, Julia Prusik, et al.. (2016). Clinical outcome and intraoperative neurophysiology for focal limb dystonic tremor without generalized dystonia treated with deep brain stimulation. Clinical Neurology and Neurosurgery. 150. 169–176. 8 indexed citations

Seegal, Richard F., Edward F. Fitzgerald, Robert J. McCaffrey, et al.. (2013). Tibial Bone Lead, but Not Serum Polychlorinated Biphenyl, Concentrations Are Associated With Neurocognitive Deficits in Former Capacitor Workers. Journal of Occupational and Environmental Medicine. 55(5). 552–562. 5 indexed citations

10.

Ramirez–Zamora, Adolfo & Eric Molho. (2013). Treatment of motor fluctuations in Parkinson’s disease: recent developments and future directions. Expert Review of Neurotherapeutics. 14(1). 93–103. 19 indexed citations

11.

Zimmerman, Earl A., et al.. (2012). Evaluation of a Prototype Point-of-care Instrument Based on Monochromatic X-Ray Fluorescence Spectrometry: Potential for Monitoring Trace Element Status of Subjects with Neurodegenerative Disease. Journal of Toxicology and Environmental Health. 75(21). 1253–1268. 13 indexed citations

12.

Seegal, Richard F., Kenneth Marek, John Seibyl, et al.. (2010). Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: A β-CIT imaging study. Neurobiology of Disease. 38(2). 219–225. 41 indexed citations

13.

Truong, Daniel, Matthew Brodsky, Mark Lew, et al.. (2010). Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism & Related Disorders. 16(5). 316–323. 119 indexed citations

14.

Factor, Stewart A., Eric Molho, Sharon Evans, & Paul J. Feustel. (2005). Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia. Movement Disorders. 20(9). 1152–1160. 36 indexed citations

15.

Factor, Stewart A., Eric Molho, Paul J. Feustel, Diane Brown, & Sharon Evans. (2001). Long-Term Comparative Experience with Tolcapone and Entacapone in Advanced Parkinson's Disease. Clinical Neuropharmacology. 24(5). 295–299. 51 indexed citations

16.

Factor, Stewart A., Diane Brown, & Eric Molho. (2000). Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease. Movement Disorders. 15(1). 167–169. 38 indexed citations

17.

Molho, Eric, Paul J. Feustel, & Stewart A. Factor. (1998). Clinical comparison of tardive and idiopathic cervical dystonia. Movement Disorders. 13(3). 486–489. 45 indexed citations

18.

Hauser, Robert A., Eric Molho, Heidi Shale, Simon C.J. Pedder, & Ernest Dorflinger. (1998). A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients. Movement Disorders. 13(4). 643–647. 37 indexed citations

19.

Tarsy, Daniel, David Kaufman, Kapil D. Sethi, et al.. (1997). An Open-Label Study of Botulinum Toxin A for Treatment of Tardive Dystonia. Clinical Neuropharmacology. 20(1). 90–93. 45 indexed citations

20.

Molho, Eric & Stewart A. Factor. (1993). Basal ganglia infarction as a possible cause of cervical dystonia. Movement Disorders. 8(2). 213–216. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact